STOCK TITAN

Insider plans 30,959-share sale in issuer (NASDAQ: SOPH) common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of SOPH filed a notice under Rule 144 to sell 30,959 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $159,748.44. These shares relate to the company’s common stock listed on NASDAQ, with 67,847,058 shares outstanding and an approximate sale date of 01/16/2026.

The securities to be sold include 23,597 shares acquired on 01/16/2026 via a cash exercise of stock options and 7,362 founder shares originally acquired on 03/18/2021. The filing also lists multiple prior Rule 10b5-1 sales over the past three months, including, for example, 95,488 shares of common stock sold on 01/09/2026 for gross proceeds of $491,626.46.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SOPH Rule 144 filing disclose about planned share sales?

The filing discloses that an insider plans to sell 30,959 shares of SOPH common stock under Rule 144, with an aggregate market value of $159,748.44, through Morgan Stanley Smith Barney LLC.

How many SOPH shares are outstanding in this Rule 144 notice?

The notice states that there are 67,847,058 shares of SOPH common stock outstanding in connection with the planned Rule 144 sale.

How were the SOPH shares in this Form 144 acquired?

According to the filing, 23,597 shares were acquired on 01/16/2026 via an exercise of stock options for cash, and 7,362 founder shares were acquired from the issuer on 03/18/2021.

On which exchange are the SOPH shares in this Rule 144 filing traded?

The filing identifies the securities as common stock listed on the NASDAQ exchange.

What prior 10b5-1 sales are reported in the SOPH Rule 144 filing?

The document lists multiple 10b5-1 sales for Jurgi Camblong over the past three months, including 95,488 shares sold on 01/09/2026 for $491,626.46 and various smaller transactions between 10/20/2025 and 01/13/2026.

Who is named as the seller in the recent SOPH 10b5-1 transactions?

The seller is identified as “10b5-1 Sales for JURGI CAMBLONG” with an address in Rolle, Switzerland, for each of the listed common stock transactions.

Who is the broker for the SOPH shares in this Rule 144 notice?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

367.73M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle